Research Output per year
Research Output per year
Fingerprint
Dive into the research topics where Medicine, Pulmonary Division is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Hiam Abdala-Valencia
- Medicine, Pulmonary Division - Associate Professor
- Robert H. Lurie Comprehensive Cancer Center - Member
Person: Academic
-
Luis A N Amaral
- Chemical and Biological Engineering - Professor, Erastus Otis Haven Professor
- Medicine, Pulmonary Division - Professor
- Physics and Astronomy - Professor
- Chemical and Biological Engineering PhD Program
- Engineering Sciences and Applied Mathematics PhD Program
- Interdisciplinary Biological Sciences PhD Program
Person: Academic
-
Accurate determination for lipidomics based on LC-tandem-MS parameters modeling, prediction, and database: Monitoring the progression of hepatocellular carcinoma
Zhang, Q., Tong, M., Xu, H., Yin, Y., Gao, P., Bi, K., Zhang, Y. & Li, Q., Jan 20 2023, In: Journal of Pharmaceutical and Biomedical Analysis. 223, 115126.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
A Complement to Traditional Treatments for Antibody-Mediated Rejection? Use of Eculizumab in Lung Transplantation: A Review and Early Center Experience
Kleiboeker, H. L., Prom, A., Paplaczyk, K. & Myers, C. N., 2023, (Accepted/In press) In: Annals of Pharmacotherapy.Research output: Contribution to journal › Review article › peer-review
-
Addressing barriers in FAIR data practices for biomedical data
the NIAID Systems Biology Data Dissemination Working Group, Dec 2023, In: Scientific Data. 10, 1, 98.Research output: Contribution to journal › Comment/debate › peer-review
Open Access4 Scopus citations
Datasets
-
Additional file 4 of Cancer-specific CTCF binding facilitates oncogenic transcriptional dysregulation
Fang, C. (Contributor), Wang, Z. (Contributor), Han, C. (Contributor), Safgren, S. L. (Creator), Helmin, K. A. (Creator), Adelman, E. R. (Creator), Serafin, V. (Creator), Basso, G. (Creator), Eagen, K. P. (Creator), Gaspar-Maia, A. (Creator), Figueroa, M. E. (Creator), Singer, B. (Creator), Ratan, A. (Contributor), Ntziachristos, P. (Creator) & Zang, C. (Creator), figshare, 2020
DOI: 10.6084/m9.figshare.12960917, https://springernature.figshare.com/articles/dataset/Additional_file_4_of_Cancer-specific_CTCF_binding_facilitates_oncogenic_transcriptional_dysregulation/12960917
Dataset
-
Giant Axonal Neuropathy alters the structure of keratin intermediate filaments in human hair_JRSocInterface_TensileSummary
Soomro, A. (Contributor), Alsop, R. J. (Creator), Negishi, A. (Creator), Kreplak, L. (Creator), Fudge, D. (Creator), Kuczmarski, E. R. (Creator), Goldman, R. (Creator), Rheinstädter, M. C. (Creator) & Goldman, R. (Creator), The Royal Society, 2017
DOI: 10.6084/m9.figshare.4818070, https://rs.figshare.com/articles/dataset/Giant_Axonal_Neuropathy_alters_the_structure_of_keratin_intermediate_filaments_in_human_hair_JRSocInterface_TensileSummary/4818070
Dataset
-
Additional file 1: of Inflammatory pathways are upregulated in the nasal epithelium in patients with idiopathic pulmonary fibrosis
Sala, M. A. (Creator), Balderas-Martínez, Y. I. (Contributor), Buendía-Roldan, I. (Contributor), Abdala-Valencia, H. (Creator), Nam, K. (Contributor), Jain, M. (Creator), Bhorade, S. (Creator), Bharat, A. (Creator), Reyfman, P. A. (Creator), Ridge, K. M. (Creator), Pardo, A. (Creator), Sznajder, J. I. (Creator), Budinger, G. S. (Contributor), Misharin, A. (Creator), Selman, M. (Creator), Ridge, K. (Creator), Pardo, A. (Creator) & Selman, M. (Creator), figshare, 2018
DOI: 10.6084/m9.figshare.7386323, https://springernature.figshare.com/articles/Additional_file_1_of_Inflammatory_pathways_are_upregulated_in_the_nasal_epithelium_in_patients_with_idiopathic_pulmonary_fibrosis/7386323
Dataset
-
Strength and Muscle Related Outcomes for Nutrition and Lung Function in Cystic Fibrosis
Jaeb Center for Health Research, Cystic Fibrosis Foundation
10/31/23 → 10/31/26
Project: Research project
-
Prot #VX21‐522‐001: A Phase 1 Single Dose Escalation Study Evaluating the Safety and Tolerability of VX‐522 in Subjects 18 Years of Age and Older With Cystic Fibrosis and a CFTR Genotype Not Responsive to CFTR Modulator Therapy
Vertex Pharmaceuticals Incorporated
10/31/23 → 10/31/26
Project: Research project
-
Prot #AV001‐004: A Randomized, Double‐blind, Placebo‐controlled, Phase 2a Multiple Ascending Dose Study to Examine the Safety, Tolerability and Efficacy of AV‐001 Injection in Patients Hospitalized with Pneumonia Due To COVID‐19 or Other Respiratory Infec
Veristat, LLC, Vasomune Therapeutics, Inc.
10/25/23 → 10/25/26
Project: Research project